EMA
approval
· 2019-03-01
New add-on treatment for patients with severe asthma
Summary
EMA announces a new add-on treatment for patients with severe asthma, indicating a fresh therapeutic option may be available in the European Union.
Upgrade for the full analysis, importance score, and drug timeline.